00:27 , Jul 21, 2017 |  BC Extra  |  Company News

Management tracks

Enzyme therapy company Aeglea BioTherapeutics Inc. (NASDAQ:AGLE) said President and CEO David Lowe resigned. Director and former interim CMO Anthony Quinn will be interim CEO while the company seeks Lowe's successor. Neurology and cardiovascular company...
00:22 , May 19, 2017 |  BC Week In Review  |  Financial News

Amyris raises $47M in first tranche of private placement

On May 11, biomanufacturing company Amyris Inc. (NASDAQ:AMRS) raised $47 million in the first tranche of a planned $95 million private placement from Royal DSM and other investors. Amyris Inc. (NASDAQ:AMRS), Emeryville, Calif. ...
23:07 , May 18, 2017 |  BC Innovations  |  Product R&D

Making cells compute

With efficiency in DNA engineering continuing to grow, and an increasing convergence between engineering and biology, synthetic biology -- in its “truest” form -- is coming within striking distance of translating preclinical proof of concept...
23:27 , Nov 10, 2016 |  BC Week In Review  |  Company News

Amyris deal

Amyris and an undisclosed company partnered to discover and develop a natural and natural-like compound library against an undisclosed target chosen by the partner. The companies will use Amyris’ uPharm technology, which identifies candidate natural...
07:00 , Oct 10, 2016 |  BC Week In Review  |  Financial News

Amyris financial update

Amyris Inc. (NASDAQ:AMRS), Emeryville, Calif.   Business: Biomanufacturing, Supply/Service   Date announced: 2016-09-30   Note: Amyris secured a five-year credit line of up to $25 million and an option for a $5 million strategic investment...
07:00 , Jun 13, 2016 |  BC Week In Review  |  Company News

Amyris, J&J deal

Amyris and Johnson & Johnson’s Janssen Biotech Inc. unit partnered to discover and develop a natural and natural-like compound library against an undisclosed target identified by Janssen. The companies will use Amyris’ uPharm platform technology,...
07:00 , Apr 18, 2016 |  BC Week In Review  |  Financial News

Amyris completes private placement

Amyris Inc. (NASDAQ:AMRS), Emeryville, Calif.   Business: Biomanufacturing, Supply/Service   Date completed: 2016-04-11   Type: Private placement   Raised: $5 million   Shares: 4.4 million   Price: $1.14   Shares after offering: 211.1 million  ...
07:00 , Apr 18, 2016 |  BC Week In Review  |  Financial News

Amyris financial update

Amyris Inc. (NASDAQ:AMRS), Emeryville, Calif.   Business: Biomanufacturing, Supply/Service   Date announced: 2016-03-08   Note: Amyris established an at-the-market program to sell up to $50 million of its shares. FBR Capital and MLV are the...
08:00 , Feb 22, 2016 |  BC Week In Review  |  Financial News

Amyris completes private placement of notes and warrants

Amyris Inc. (NASDAQ:AMRS), Emeryville, Calif.   Business: Biomanufacturing, Supply/Service   Date completed: 2016-02-19   Type: Private placement of notes and warrants   Raised: $20 million   Investors: Foris Ventures LLC; Naxyris S.A.; Biolding Investment S.A....
07:00 , Oct 19, 2015 |  BC Week In Review  |  Financial News

Amyris completes private placement of senior convertible notes

Amyris Inc. (NASDAQ:AMRS), Emeryville, Calif.   Business: Biomanufacturing, Supply/Service   Date completed: 2015-10-15   Type: Private placement of senior convertible notes   Raised: $57.6 million   Shares outstanding prior: 157.5 million   Investor: Institutional investors...